New Study Finds No Safety Concerns in HPV Vaccine During Pregnancy

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

New Study Finds No Safety Concerns in HPV Vaccine During Pregnancy

A new CDC study looking at human papillomavirus (HPV) vaccination during pregnancy was published in the journal Vaccine this week.
vaccinesafety-HPV Researchers reviewed reports to the Vaccine Adverse Event Reporting System (VAERS) about women who received the HPV vaccine Gardasil® while they were pregnant. Gardasil® is not currently recommended for pregnant women, given the limited available safety data in pregnancy. However, because catchup vaccination is recommended for women through age 26, there is a possibility that some women will receive the vaccine before realizing that they are pregnant. This study found no patterns of safety concerns for pregnant woman who received Gardasil®, or for their babies.
This study adds to the literature on the safety of HPV vaccination during pregnancy. Gardasil®’s manufacturer, Merck, maintained a Gardasil® Pregnancy Registry from 2006 to 2012. No safety concerns were noted in this registry.

For more information on HPV vaccine safety, see:

The CDC has reached 1 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support.

CDC 24/7 - Saving Lives, Protecting People, Saving Money. Dept of Health and Human Services Logo Learn Vital Information about HIV Medical Care
CDC on Facebook CDC on Twitter CDC YouTube Channel

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: